Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Allen

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Diagnostic Microbiology and Infectious Disease|February 16, 2025
A real-world investigation into prescribing patterns and effectiveness of ceftolozane/tazobactam among critically ill patients from SPECTRAAlex Soriano, David L Paterson, Florian Thalhalmmer, et al.
Journal of Global Antimicrobial Resistance|January 26, 2025
Unveiling results and insights from multinational, multicenter Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam Real-world Analysis (SPECTRA)Alex Soriano, David L Paterson, Florian Thalhammer, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2005
A series of bisaryl imidazolidin-2-ones has shown to be selective and orally active 5-HT2C receptor antagonistsCaroline J Goodacre, Steven M Bromidge, David Clapham, et al.
Bioanalysis|April 20, 2012
4th Global CRO Council for Bioanalysis: coadministered drugs stability, EMA/US FDA guidelines, 483s and carryoverSteve Lowes, Jim Jersey, Ronald Shoup, et al.
Bioanalysis|June 18, 2011
Recommendations on: internal standard criteria, stability, incurred sample reanalysis and recent 483s by the Global CRO Council for BioanalysisSteve Lowes, Jim Jersey, Ronald Shoup, et al.
Bioanalysis|February 27, 2016
9th GCC closed forum: CAPA in regulated bioanalysis; method robustness, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, regulatory audit experiences and electronic laboratory notebooksRoger Hayes, Richard LeLacheur, Isabelle Dumont, et al.
Bioanalysis|December 16, 2014
8th GCC: consolidated feedback to US FDA on the 2013 draft FDA guidance on bioanalytical method validationJoseph Bower, Douglas Fast, Fabio Garofolo, et al.
Bioanalysis|March 29, 2012
Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC)Mark Boterman, Mira Doig, Massimo Breda, et al.
Bioanalysis|September 28, 2012
Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC)Steve Lowes, Mark Boterman, Mira Doig, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Diagnostic Microbiology and Infectious Disease|February 16, 2025
A real-world investigation into prescribing patterns and effectiveness of ceftolozane/tazobactam among critically ill patients from SPECTRAAlex Soriano, David L Paterson, Florian Thalhalmmer, et al.
Journal of Global Antimicrobial Resistance|January 26, 2025
Unveiling results and insights from multinational, multicenter Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam Real-world Analysis (SPECTRA)Alex Soriano, David L Paterson, Florian Thalhammer, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2005
A series of bisaryl imidazolidin-2-ones has shown to be selective and orally active 5-HT2C receptor antagonistsCaroline J Goodacre, Steven M Bromidge, David Clapham, et al.
Bioanalysis|April 20, 2012
4th Global CRO Council for Bioanalysis: coadministered drugs stability, EMA/US FDA guidelines, 483s and carryoverSteve Lowes, Jim Jersey, Ronald Shoup, et al.
Bioanalysis|June 18, 2011
Recommendations on: internal standard criteria, stability, incurred sample reanalysis and recent 483s by the Global CRO Council for BioanalysisSteve Lowes, Jim Jersey, Ronald Shoup, et al.
Bioanalysis|February 27, 2016
9th GCC closed forum: CAPA in regulated bioanalysis; method robustness, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, regulatory audit experiences and electronic laboratory notebooksRoger Hayes, Richard LeLacheur, Isabelle Dumont, et al.
Bioanalysis|December 16, 2014
8th GCC: consolidated feedback to US FDA on the 2013 draft FDA guidance on bioanalytical method validationJoseph Bower, Douglas Fast, Fabio Garofolo, et al.
Bioanalysis|March 29, 2012
Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC)Mark Boterman, Mira Doig, Massimo Breda, et al.
Bioanalysis|September 28, 2012
Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC)Steve Lowes, Mark Boterman, Mira Doig, et al.
Pageof 4